Publication: Cross-protective capacity of Japanese Encephalitis (JE) vaccines against circulating Heterologous JE Virus genotypes
| dc.contributor.author | Erra, Elina O. | en_US |
| dc.contributor.author | Askling, Helena Hervius | en_US |
| dc.contributor.author | Sutee Yoksan | en_US |
| dc.contributor.author | Rombo, Lars | en_US |
| dc.contributor.author | Riutta, Jukka | en_US |
| dc.contributor.author | Vene, Sirkka | en_US |
| dc.contributor.author | Lindquist, Lars | en_US |
| dc.contributor.author | Vapalahti, Olli | en_US |
| dc.contributor.author | Anu Kantele | en_US |
| dc.contributor.other | Mahidol University. Institute of Molecular Biosciences | en_US |
| dc.date.accessioned | 2015-06-08T12:19:38Z | |
| dc.date.accessioned | 2017-04-25T03:40:56Z | |
| dc.date.available | 2015-06-08T12:19:38Z | |
| dc.date.available | 2017-04-25T03:40:56Z | |
| dc.date.created | 2015-06-08 | |
| dc.date.issued | 2013-01 | |
| dc.description.abstract | Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I–IV. | en_US |
| dc.identifier.citation | Clinical Infectious Diseases. Vol.56, No.2 (2013), 267-270 | en_US |
| dc.identifier.doi | 10.1093/cid/cis883 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/1820 | |
| dc.language.iso | eng | en_US |
| dc.rights | Mahidol University | en_US |
| dc.subject | Japanese encephalitis | en_US |
| dc.subject | vaccine | en_US |
| dc.subject | traveler | en_US |
| dc.subject | crossreactive immunity | en_US |
| dc.subject | flavivirus | en_US |
| dc.subject | Open Access article | en_US |
| dc.title | Cross-protective capacity of Japanese Encephalitis (JE) vaccines against circulating Heterologous JE Virus genotypes | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |